{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:53:23Z","timestamp":1793386403472,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007051","name":"Mellam Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainstimjrnl.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Stimulation"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.brs.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:18:10Z","timestamp":1744150690000},"page":"875-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3483-026X","authenticated-orcid":false,"given":"Andrew D.","family":"Geoly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5919-9673","authenticated-orcid":false,"given":"Katy H.","family":"Stimpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flint M.","family":"Espil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6014-4514","authenticated-orcid":false,"given":"Brandon S.","family":"Bentzley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolan R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brs.2025.04.006_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.3826","article-title":"Depression is the leading cause of disability around the World","volume":"317","author":"Friedrich","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.brs.2025.04.006_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment\u2010resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.brs.2025.04.006_bib4","series-title":"Developing drugs for treatment guidance for industry","year":"2018"},{"key":"10.1016\/j.brs.2025.04.006_bib5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.biopsych.2007.01.018","article-title":"Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial","volume":"62","author":"O'Reardon","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.brs.2025.04.006_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archgenpsychiatry.2010.46","article-title":"Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial","volume":"67","author":"George","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.brs.2025.04.006_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/da.21969","article-title":"Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice","volume":"29","author":"Carpenter","year":"2012","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.brs.2025.04.006_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jad.2008.10.014","article-title":"What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies","volume":"116","author":"Fekadu","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2025.04.006_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brs.2018.10.001","article-title":"Durability of antidepressant response to repetitive transcranial magnetic stimulation: systematic review and meta-analysis","volume":"12","author":"Senova","year":"2019","journal-title":"Brain Stimul"},{"key":"10.1016\/j.brs.2025.04.006_bib10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.4088\/JCP.13m08977","article-title":"A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period","volume":"75","author":"Dunner","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.brs.2025.04.006_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awx379","article-title":"High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression","volume":"141","author":"Williams","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.brs.2025.04.006_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4088\/JCP.08m04309","article-title":"A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method","volume":"70","author":"Fekadu","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.brs.2025.04.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/jn.00537.2019","article-title":"Is accelerated, high-dose theta burst stimulation a panacea for treatment-resistant depression?","volume":"123","author":"Caulfield","year":"2020","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.brs.2025.04.006_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/appi.ajp.2019.19070720","article-title":"Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression","volume":"177","author":"Cole","year":"2020","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.brs.2025.04.006_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1176\/appi.ajp.2021.20101429","article-title":"Stanford neuromodulation therapy (SNT): a double-blind randomized controlled trial","volume":"179","author":"Cole","year":"2022","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.brs.2025.04.006_bib16","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1152\/jn.00067.2005","article-title":"Simple metric for scaling motor threshold based on scalp-cortex distance: application to studies using transcranial magnetic stimulation","volume":"94","author":"Stokes","year":"2005","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.brs.2025.04.006_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1152\/jn.00510.2012","article-title":"Biophysical determinants of transcranial magnetic stimulation: effects of excitability and depth of targeted area","volume":"109","author":"Stokes","year":"2013","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.brs.2025.04.006_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/104012371402600310","article-title":"Defining treatment-resistant depression: a comprehensive review of the literature","volume":"26","author":"Trevino","year":"2014","journal-title":"Ann Clin Psychiatry Off J Am Acad Clin Psychiatr"},{"key":"10.1016\/j.brs.2025.04.006_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0447.1975.tb00002.x","article-title":"Quantitative rating of depressive states","volume":"51","author":"Bech","year":"1975","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.brs.2025.04.006_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"10.1016\/j.brs.2025.04.006_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12888-019-2410-2","article-title":"Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial","volume":"19","author":"Dunlop","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.brs.2025.04.006_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000457131","article-title":"A systematic review of the clinimetric properties of the 6-item version of the Hamilton Depression Rating Scale (HAM-D6)","volume":"86","author":"Timmerby","year":"2017","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.brs.2025.04.006_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jpsychires.2004.03.007","article-title":"Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression","volume":"38","author":"Zimmerman","year":"2004","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.brs.2025.04.006_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3348\/kjr.2022.0061","article-title":"Restricted mean survival time for survival analysis: a quick guide for clinical researchers","volume":"23","author":"Han","year":"2022","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.brs.2025.04.006_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpsychires.2019.03.021","article-title":"The assessment of resistance to antidepressant treatment: rationale for the antidepressant treatment history form: short form (ATHF-SF)","volume":"113","author":"Sackeim","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.brs.2025.04.006_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/08039480601151238","article-title":"Psychiatric outcome studies (POS): does treatment help the patients? A Popperian approach to research in clinical psychiatry: 25th anniversary report from the Psychiatric Research Unit, Frederiksborg General Hospital, Denmark","volume":"61","author":"Bech","year":"2007","journal-title":"Nord J Psychiatr"},{"key":"10.1016\/j.brs.2025.04.006_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(02)00120-9","article-title":"Differentiating moderate and severe depression using the Montgomery\u2013\u00c5sberg depression rating scale (MADRS)","volume":"77","author":"M\u00fcller","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2025.04.006_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1192\/bjp.2017.28","article-title":"Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis","volume":"212","author":"Diermen","year":"2018","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.brs.2025.04.006_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.869070","article-title":"Sex\/gender as a factor that influences transcranial magnetic stimulation treatment outcome: three potential biological explanations","volume":"13","author":"Hanlon","year":"2022","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.brs.2025.04.006_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2020.08.005","article-title":"Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation","volume":"277","author":"Sackeim","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2025.04.006_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.9758\/cpn.2019.17.1.25","article-title":"Predictors of response to repetitive transcranial magnetic stimulation in depression: a review of recent updates","volume":"17","author":"Kar","year":"2019","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.brs.2025.04.006_bib32","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(18)30295-2","article-title":"Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial","volume":"391","author":"Blumberger","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.brs.2025.04.006_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2020.03.002","article-title":"Evaluation of the effects of rTMS on self-reported quality of life and disability in treatment-resistant depression: a THREE-D study","volume":"268","author":"Giacobbe","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2025.04.006_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41591-023-02764-z","article-title":"Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trial","volume":"30","author":"Morriss","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.brs.2025.04.006_bib35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.brs.2025.04.006_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jval.2015.04.004","article-title":"Cost-effectiveness of repetitive transcranial magnetic stimulation versus antidepressant therapy for treatment-resistant depression","volume":"18","author":"Nguyen","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.brs.2025.04.006_bib37","first-page":"187","article-title":"Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study","volume":"3","author":"Janicak","year":"2010","journal-title":"Brain Stimul Basic Transl Clin Res Neuromodulation"},{"key":"10.1016\/j.brs.2025.04.006_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115179","article-title":"Deep TMS H1 Coil treatment for depression: results from a large post marketing data analysis","volume":"324","author":"Tendler","year":"2023","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.brs.2025.04.006_bib39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/da.21967","article-title":"Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (tms) in treatmnt-resistant depression","volume":"29","author":"Mantovani","year":"2012","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.brs.2025.04.006_bib40","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1056\/NEJMct075234","article-title":"Electroconvulsive therapy for depression","volume":"357","author":"Lisanby","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brs.2025.04.006_bib41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMra2034954","article-title":"Electroconvulsive therapy","volume":"386","author":"Espinoza","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brs.2025.04.006_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00124509-200112000-00003","article-title":"ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from core","volume":"17","author":"Petrides","year":"2001","journal-title":"J ECT"},{"key":"10.1016\/j.brs.2025.04.006_bib43","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","article-title":"Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis","volume":"30","author":"Heijnen","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.brs.2025.04.006_bib44","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/npp.2013.149","article-title":"Relapse following successful electroconvulsive therapy for major depression: a meta-analysis","volume":"38","author":"Jelovac","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brs.2025.04.006_bib45","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.brs.2025.04.006_bib46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000457960","article-title":"Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression","volume":"86","author":"Wilkinson","year":"2017","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.brs.2025.04.006_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0004867416631828","article-title":"Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation","volume":"51","author":"Cusin","year":"2017","journal-title":"Aust N Z J Psychiatr"},{"key":"10.1016\/j.brs.2025.04.006_bib48","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brs.2025.04.006_bib49","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.euroneuro.2006.04.008","article-title":"The Montgomery \u00e4sberg and the Hamilton ratings of depression","volume":"16","author":"Carmody","year":"2006","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"10.1016\/j.brs.2025.04.006_bib50","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s12325-021-01732-8","article-title":"Strategies to prolong ketamine's efficacy in adults with treatment-resistant depression","volume":"38","author":"McMullen","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.brs.2025.04.006_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.20230113","article-title":"Sustained efficacy of Stanford neuromodulation therapy (SNT) in open-label repeated treatment","volume":"181","author":"Geoly","year":"2024","journal-title":"Am J Psychiatr"}],"container-title":["Brain Stimulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X25000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X25000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:36:04Z","timestamp":1762562164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X25000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1935861X25000877"],"URL":"https:\/\/doi.org\/10.1016\/j.brs.2025.04.006","relation":{},"ISSN":["1935-861X"],"issn-type":[{"value":"1935-861X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression","name":"articletitle","label":"Article Title"},{"value":"Brain Stimulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brs.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}